Wyeth is a world leader in the research and development of innovative, high-quality health care products. Our product portfolio spans the range of top-selling pharmaceutical and biotechnology products, consumer health care products, and animal health care products.
For over a century, Wyeth has been improving the lives of millions of people in Canada and around the world.
They have leading products in women’s health, neuroscience, immunology, vaccines and infectious disease, musculoskeletal disorders, hemophilia, and transplantation, and are driving innovation even further as they explore more than 60 new therapies to battle breast cancer, diabetes, HIV, schizophrenia, and Alzheimer’s disease.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. They are a global leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription (“over-the-counter”) medicines that improve the quality of life for people around the world.
Wyeth is one of the fastest growing pharmaceutical companies in Canada. They have over 1,900 employees across Canada whose talent, commitment, and experience drive all their efforts. The common values that they share—quality, integrity, respect for people, leadership, and collaboration—allow them to contribute to the overall corporate goal of being recognized as the best pharmaceutical company in Canada and the world.
Their product portfolio covers a wide range of therapeutic areas including women’s health care, neuroscience, musculoskeletal disorders, cardiovascular therapy, vaccines and infectious disease treatment, hemophilia, immunology, and oncology. Our key global brands include Effexor® XR, Rapamune®, Prevnar®, Premarin®, Enbrel®,Tazocin®, Tygacil® and Alesse®.
At Wyeth, their eyes are on the future and their commitment to research and development is clear evidence of that focus. Wyeth Canada invested $64.5 million (CDN) in 2005, an increase of 83% since 2000, to support research and development in Canada.
For more information, please contact:
Ron Cherepuschak, Managing Director chereprj@wyeth.com
(204) 728-1511
720- 17th Street East, Brandon, MB, Canada, R7A 7H2
This page made possible by LSAM's exclusive sector directory sponsor.
